Viewing Study NCT06651437



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06651437
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-05

Brief Title: Salt Consumption After the Administration of Rapid Questionnaire MINISAL-SIIA STUDY
Sponsor: None
Organization: None

Study Overview

Official Title: A Nutritional Questionnaire in an Adult Italian Hypertensive Population Effects on Sodium and Potassium Intake MINISAL-SIIA STUDY
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MINISAL-SIIA
Brief Summary: A strong and well-known association exists between salt consumption potassium intake and cardiovascular diseases MINISAL-SIIA results showed high salt and low potassium consumption in Italian hypertensive patients In addition a recent Italian survey showed that the degree of knowledge and behavior about salt was directly interrelated suggesting a key role of the educational approach Therefore the present study will aim to evaluate the efficacy of a short-time dietary educational intervention MINIMAL-ADVICE on sodium and potassium intake in hypertensive patients
Detailed Description: High salt consumption is an important determinant of high blood pressure BP and cardiovascular diseases Several intervention studies showed that a reduction in salt consumption reduces BP and can reduce cardiovascular risk beyond the beneficial effect on BP in people with and without hypertension The World Health Organization WHO recommends that adults should consume no more than 5 g of salt daily However the mean daily intake of salt in the majority of countries worldwide exceeds this recommendation In contrast to salt epidemiological and intervention studies suggest beneficial effects of dietary potassium on BP and cardiovascular risk This effect seems more pronounced during high salt consumption The WHO currently also recommends that adults should consume not less than 90 mmol of potassium daily However also for potassium the WHO recommendations are not generally met

Several countries have made some progress towards reducing habitual salt intake through a voluntary or regulatory approach achieving a reduction of BP and cardiovascular disease in the young population Our previous observational data detected that Italian general population samples consumed high dietary salt and low dietary potassium far from the WHO guidelines recommendation Excess dietary salt intake in the hypertensive patients population was observed in all age categories and there were no differences in salt intake among different regions Likewise in the same hypertensive population the adequate potassium intake in both men and women in all age categories and in all the regions surveyed was much below the recommendation These results point out the potential target to improve BP and cardiovascular risk in particular in hypertensive patients An Italian survey of a large cohort of the general population showed that the degree of knowledge and behaviour about salt was directly interrelated These data suggested that educational approach is crucial to improve the level of salt consumption The reduction of salt intake has been recommended by WHO as a cost-effective action that should be undertaken Hence an intervention study targeted to reduce dietary salt intake and also to increase dietary potassium consumption by an educational intervention is needed

Given these premises the aim of the present intervention study will be to evaluate the effect of a brief educational intervention MINIMAL-ADVICE for improving dietary salt and potassium intake in a hypertensive population In addition the effect of the educational intervention on BP in relation to the potential variation of salt and potassium intake will be also evaluated

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None